Staar Ovarian Cancer
- Assets
- $448.0k
- Revenue
- $399.6k
- Investments
- $0.0
- Employees
- 0
- Location
- Chicago, IL
- Founding
- Data as of
- 12/2023
- EIN
- 84-4672869
Organization Overview
Staar Ovarian Cancer is located in Chicago, IL. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Staar Ovarian Cancer is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Staar Ovarian Cancer generated $399.6k in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 42.6% each year . All expenses for the organization totaled $277.1k during the year ending 12/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
STAAR EXISTS TO ADVOCATE FOR AND RAISE FUNDS FOR RESEARCH SPECIFICALLY ON THE LOW-GRADE SEROUS CARCINOMA SUB-TYPLE OF OVARIAN CANCER IN THE UNITED STATES. WE DRIVE AWARENESS OF THE SYMPTOBS OF OVARIAN CANCER AND THE UNDER-FUNDING OF RESEARCH FOR THE LGSC SUB-TYPE. WE STRENGTHEN OUR CONNECTIONS WITH RESEARCHERS TO UNDERSTAND RESEARCH NEEDS, FUNDING NEEDS, AND HISTORICALLY RAISED ENOUGH FUNDS THROUGH DONATIONS TO GIVE THREE RESEARCH GRANTS FOR LGSOC. ONE OF THE FUNDED STUDIES WAS FUNDED WITH MONEY DONATED IN 2021.
Describe the Organization's Program Activity:
Part 3 - Line 4a
CONTINUING SUPPORTING AND EXPANDING AN AWARENESS CAMPAIGN OF LGSOC.
ANY OTHER MARKETING RESEARCH SUPPORT SERVICES THAT BENEFITS AWARENESS OF LGSC SUB-TYPE.
AWARDED RESEARCH GRANTS FOR LGSOC
CREATED AND CONDUCTED A SURVERY OF LGSOC PATIENTS PERPECTIVES ON TREATMENTS AND DOCTOR INTERACTIONS WHICH ARE PRESENTED AT LGSOC RESEARCH CONFERENCE. PLAN, SUPPORT, AND HOLD AN EXTERNALLY-LED PATIENT FOCUSED DRUG DEVELOPMENT MEETING AS DIRECTED BY THE US FDA FOR PATIENTS TO PRESENT THEIR PERSPECTIVES ON LIVING WITH THEIR RARE DISEASE AND THEIR DAILY LIFE WITH THE CURRENT TREATMENTS. PROVIDE A PLATFORM FOR PATIENTS TO SHARE THEIR THOUGHTS ON DRUG DEVELOPMENT AND SIDE EFFECTS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Ellie Habib Director | Trustee | 2 | $0 |
Madalyn Kenney Director | Trustee | 1 | $0 |
Bailey Wolfe Director | Trustee | 1 | $0 |
Nicole Andrews Chair | Officer | 10 | $0 |
Christina Campbell Treasurer | Officer | 2 | $0 |
Morgan Gaynor Secretary | Officer | 2 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $327,751 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $327,751 |
| Total Program Service Revenue | $71,500 |
| Investment income | $337 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $399,588 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $153,000 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $2,107 |
| Fees for services: Accounting | $441 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $78,965 |
| Advertising and promotion | $598 |
| Office expenses | $2,580 |
| Information technology | $2,052 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $0 |
| All other expenses | $37,324 |
| Total functional expenses | $277,067 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $448,000 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $448,000 |
| Accounts payable and accrued expenses | $299,152 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $299,152 |
| Net assets without donor restrictions | $148,848 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $448,000 |
Grants Awarded
Over the last fiscal year, Staar Ovarian Cancer has awarded $153,000 in support to 2 organizations.
| Grant Recipient | Amount |
|---|---|
THE UNIVERSITY OF TEXAS MD ANDERSONCANCER CENTER PURPOSE: RESEARCH ON LOW | $53,000 |
UNIVERSITY OF OKLAHOMA HEALTHSYSTEMS | | | $100,000 |